ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

C.R. Bard 1Q Profit Rises 8.8% On Vascular Sales

DOW JONES NEWSWIRES Medical-device maker C.R. Bard Inc.'s (BCR) first-quarter profit rose a better-than-expected 8.8% on revenue growth in its main vascular business. A rebound in spending in the health-care sector has driven renewed profits at companies like C.R. Bard, which has posted solid revenue growth on strong performance in the vascular business, its largest by revenue. The company has also worked to control costs. "Through the strength of our diversified portfolio, we delivered strong revenue and earnings growth again this quarter, despite the fact that we saw no measurable improvement in hospital volumes and procedures," Chairman and Chief Executive Timothy M. Ring said. C.R. Bard posted a first-quarter profit of $131.9 million, or 1.49 cents a share, up from $120.9 million, or $1.24 a share, a year earlier. Excluding acquisition-related charges, prior-year restructuring costs and other items, earnings rose to $1.51 from $1.25 a share. Revenue rose 7.6% to $700.3 million on both a reported and a constant-currency basis. The company in January projected a per-share profit of $1.43 to $1.47 on 6% to 8% revenue growth. Gross margin rose to 62.2% from 61.2%. Sales in the urology segment edged up 3%, while vascular business revenue jumped 15%. Oncology and surgical specialties revenues grew 7.1% and 5.2%, respectively. Shares rose 1.3% to $104.46 after-hours. The stock has climbed 20% over the past year through the close. -By Drew FitzGerald, Dow Jones Newswires; 212-416-2909; Andrew.FitzGerald@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
03/30/201510:19:38The Best Stocks To Buy This Week
03/26/201503:20:53Top Large Cap Stocks That Investors Can Buy Now
03/25/201509:39:29Statement of Changes in Beneficial Ownership (4)
03/13/201513:21:30Proxy Statement (definitive) (def 14a)
03/07/201500:36:53Ranking The Dividend Champions
03/06/201508:04:35J & J on the hook for $5.7M in California mesh trial
03/04/201512:00:00Bard to Present at Barclays Global Healthcare Conference
03/01/201505:02:23Some Companies Are More Wonderful Than Others
03/01/201504:33:35The Best Scoring Stocks To Buy Now
02/26/201518:22:23Statement of Changes in Beneficial Ownership (4)
02/25/201510:30:00Bard to Present at Raymond James Institutional Investors Conference
02/20/201515:52:13Statement of Changes in Beneficial Ownership (4)
02/20/201515:52:13Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/19/201517:30:38Statement of Changes in Beneficial Ownership (4)
02/19/201511:52:00CMS Approves Pass-Through Payment for Lutonix DCB for Outpatient...

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad